This HTML5 document contains 195 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34247727
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en 2008 2008年论文 2008 թվականի մարտին հրատարակված գիտական հոդված научни чланак 2008年论文 wetenschappelijk artikel מאמר מדעי vitenskapelig artikkel 2008年論文 наукова стаття, опублікована в березні 2008 научна статия article científic artikull shkencor naučni članak articol științific 2008年論文 vedecký článok wissenschaftlicher Artikel artigo científico (publicado na 2008) articolo scientifico artigo científico bilimsel makale article scientifique (publié 2008) artículo científico publicado en 2008 bài báo khoa học vědecký článek 2008年论文 videnskabelig artikel (udgivet 2008) επιστημονικό άρθρο scientific article teaduslik artikkel 2008년 논문 vetenskaplig artikel 2008年論文 2008年の論文 مقالهٔ علمی научная статья 2008年论文 سائنسی مضمون artykuł naukowy artikulong pang-agham სამეცნიერო სტატია 2008年论文 2008年論文 научни чланак mokslinis straipsnis artigo científico (publicado na 2008) 2008 nî lūn-bûn article scientific 2008年论文 ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ บทความทางวิทยาศาสตร์ 2008 թուականի Մարտին հրատարակուած գիտական յօդուած мақолаи илмӣ مقالة علمية мақолаи илмӣ vitskapeleg artikkel tudományos cikk scienca artikolo tieteellinen artikkeli 2008年論文
p:P577
wds:Q34247727-ADE02FA4-6BAB-4B54-AEDB-62C2BA63DE85
wdt:P577
2008-03-31T00:00:00Z
p:P407
wds:Q34247727-D3D025F7-3B02-4CF9-9322-4FFE99D5FA3A
wdt:P407
wd:Q1860
p:P2860
wds:Q34247727-14E671A2-0A94-454E-8745-B3918728D18E wds:Q34247727-212D7FC3-8DFF-496A-A301-BCE6507A0958 wds:Q34247727-21A950C7-4CF5-49A7-B207-F05FE4D9B335 wds:Q34247727-2E04DF05-B3FA-4020-A0A9-FD9744C70806 wds:Q34247727-0BA77CFC-A4C7-4BCD-B9E3-58E0CFFDFB73 wds:Q34247727-4B44CB1D-E88E-4EA3-8D4E-1286459E1D7A wds:Q34247727-53676EA1-34B9-4B9B-A4A1-BAE5569D5833 wds:Q34247727-70BFF6B6-1FE8-4EC1-AEBF-F85DE26DB2FB wds:Q34247727-327009A6-F108-40E3-91C1-EEFB6E5BD0EF wds:Q34247727-3D9361BD-E241-48A2-9D00-10CE1B4283BB wds:Q34247727-421A8670-BBAF-4BC8-B0B6-4C182AEF3272 wds:Q34247727-49E798A7-937F-4FA9-A95B-D7519946C743 wds:Q34247727-97A3E689-D98E-4A8B-A7BF-CE7FF1593F05 wds:Q34247727-A1654D9A-6ADA-49F9-A542-040385B8643E wds:Q34247727-7A7B34D3-02AE-449D-A676-B6D4C8847F12 wds:Q34247727-87AF4C4A-0567-4B9C-9955-D2D219EEC7C9 wds:Q34247727-BDCBF3C2-5B8F-456A-964A-8E7F08ED7763 wds:Q34247727-BEFC2C0A-3FFC-4CFC-8960-BB467F49E6B2 wds:Q34247727-BF4C8E28-7D7F-41AD-AC38-366F84D25025 wds:Q34247727-CD7C9119-692F-497F-AA1D-BF0408ADDFE6 wds:Q34247727-B0BC88C4-C048-4C23-A082-FBF1F219F979 wds:Q34247727-F3ED551D-A3B2-490A-862F-BE6D69C7029B wds:Q34247727-FD30C3B3-9F03-40D0-A8AE-9FE01EC4B504 wds:Q34247727-D0845DB6-91BD-4143-93D0-D5FD131C639E wds:Q34247727-D861F334-9D4D-499C-B95E-9F6406802475 wds:Q34247727-DA83C464-BC7D-4C77-81EA-6D79DF698872 wds:Q34247727-DAAC7BB1-69F6-4CF2-AB57-73782108215B wds:Q34247727-DD4391CB-3135-47F8-8E8E-320A2FD4DEFA
wdt:P2860
wd:Q28219713 wd:Q28200375 wd:Q28200368 wd:Q34576407 wd:Q28212030 wd:Q34245387 wd:Q73462671 wd:Q28138338 wd:Q28217835 wd:Q45260921 wd:Q34803113 wd:Q28210559 wd:Q44851038 wd:Q29620087 wd:Q36215336 wd:Q34086325 wd:Q34604937 wd:Q35575626 wd:Q36945227 wd:Q46885948 wd:Q36591918 wd:Q33985078 wd:Q34356732 wd:Q22241923 wd:Q46972826 wd:Q34570463 wd:Q44958643 wd:Q34087109
p:P2093
wds:Q34247727-B52EEC71-742D-4A54-B12F-C4A65491251C wds:Q34247727-BA092AA6-77BB-4E65-B00D-528B6AEA5829 wds:Q34247727-989CD5F2-5C88-40D0-98DB-FC59478EE2BA wds:Q34247727-94D5DCE2-3480-47F6-9915-05F4EE79F6BB wds:Q34247727-925FC519-E125-4A97-8946-80BB4F76A868 wds:Q34247727-70F3890C-F387-4DA0-89CB-513CC0C38062 wds:Q34247727-588FC215-B8F2-407B-BFD6-7A198DF6DF71 wds:Q34247727-4912026D-1611-4609-9C7A-96027F6C76A4 wds:Q34247727-34EBA42B-3EF2-4434-899A-59C05D32BBEB wds:Q34247727-26790C4F-870F-4B3B-A2E4-CBC324FEF82B wds:Q34247727-1745C1E4-138D-4416-BC16-136F62C57DAE wds:Q34247727-0D88870F-2043-462C-84F1-B18DFFBD041C wds:Q34247727-0B6726BD-4EED-4587-B073-06EEEAC621D4 wds:Q34247727-0389E473-641F-4F81-8A8F-41DF21E470E5 wds:Q34247727-EA317619-4178-4969-BDAD-6BEAECC481EE wds:Q34247727-EA20A1B8-3C9A-4DB4-9D6B-18F9BC69738F
wdt:P2093
Jonghyeon Kim Barbara Martin Scott D Solomon Gretchen Arndt Ernest Hawk Paul E Goss Nadir Arber Bernard Levin Joseph L Pater Robert Fowler Peter V Finn Jaye Viner Peter Lance Cross Trial Safety Assessment Group Stefanie Obara Curtis L Meinert
rdfs:label
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis
skos:prefLabel
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis
schema:name
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis
p:P50
wds:Q34247727-7628AA77-6F44-4C8B-8B0D-B4589230BBB1 wds:Q34247727-01C02504-EA68-4397-A40F-653C24C4AABE wds:Q34247727-C47F3A27-D41D-4B52-A383-5480AA0FB6F9
wdt:P50
wd:Q24266614 wd:Q91718593 wd:Q60902988
p:P1476
wds:Q34247727-438AC828-52CC-460D-9258-40E092243CBC
wdt:P1476
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis
p:P304
wds:Q34247727-6B9BE40A-0382-4CE4-9A81-D517996C0317
wdt:P304
2104-2113
p:P31
wds:Q34247727-aeaf5fee-f767-4cd8-8edd-ccd7128d63b4 wds:Q34247727-A8A75E00-B3EB-46A4-801A-5FBFECB731AC
wdt:P31
wd:Q815382 wd:Q13442814
p:P921
wds:Q34247727-B04FB65A-C8C1-4066-9991-DA128C0B3A0E wds:Q34247727-68C88CF3-493F-4AAA-92DD-2905FA348A49
wdt:P921
wd:Q269829 wd:Q11068
p:P698
wds:Q34247727-DACCAB8C-94E6-429D-A77C-C609DEDC1B4A
wdtn:P698
n8:18378608
wdt:P698
18378608
p:P1433
wds:Q34247727-331291D7-AED6-4BAE-8DE1-1D6F5E785B89
wdt:P1433
wd:Q578091
p:P433
wds:Q34247727-84EDFB6B-752A-4937-8EB7-0F4042D1577D
p:P478
wds:Q34247727-FA71C1D6-9357-43CA-8D8B-DF61483058B8
wdt:P433
16
wdt:P478
117
p:P356
wds:Q34247727-C6D73518-5F4B-47E6-9539-0FB2717240C6
wdtn:P356
n11:CIRCULATIONAHA.108.764530
wdt:P356
10.1161/CIRCULATIONAHA.108.764530
p:P932
wds:Q34247727-2D534EAE-12F7-4848-A632-CDABC64B1B27
wdt:P932
2965408